DAFNA Capital Management’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $952K | Hold |
1,704,232
| – | – | 0.26% | 60 |
|
|
2025
Q1 | $811K | Hold |
1,704,232
| – | – | 0.23% | 64 |
|
|
2024
Q4 | $1.72M | Hold |
1,704,232
| – | – | 0.44% | 45 |
|
|
2024
Q3 | $2.91M | Hold |
1,704,232
| – | – | 0.69% | 38 |
|
|
2024
Q2 | $4.35M | Buy |
1,704,232
+396,825
| +30% | +$1.01M | 1.04% | 28 |
|
|
2024
Q1 | $5.46M | Hold |
1,307,407
| – | – | 1.24% | 26 |
|
|
2023
Q4 | $4.34M | Hold |
1,307,407
| – | – | 1.04% | 32 |
|
|
2023
Q3 | $2.61M | Hold |
1,307,407
| – | – | 0.81% | 33 |
|
|
2023
Q2 | $4.13M | Hold |
1,307,407
| – | – | 1.13% | 27 |
|
|
2023
Q1 | $4.54M | Buy |
1,307,407
+832,040
| +175% | +$2.89M | 1.36% | 27 |
|
|
2022
Q4 | $2.44M | Hold |
475,367
| – | – | 0.69% | 40 |
|
|
2022
Q3 | $4.7M | Hold |
475,367
| – | – | 1.26% | 26 |
|
|
2022
Q2 | $3.99M | Buy |
475,367
+218,475
| +85% | +$1.84M | 1.09% | 29 |
|
|
2022
Q1 | $3.23M | Buy |
256,892
+156,757
| +157% | +$1.97M | 0.84% | 33 |
|
|
2021
Q4 | $1.59M | Buy |
100,135
+20,135
| +25% | +$319K | 0.4% | 50 |
|
|
2021
Q3 | $2.01M | Hold |
80,000
| – | – | 0.53% | 46 |
|
|
2021
Q2 | $2.35M | Buy |
+80,000
| New | +$2.35M | 0.49% | 44 |
|